184 related articles for article (PubMed ID: 19276354)
1. A role for CXCR2 in senescence, but what about in cancer?
Acosta JC; Gil J
Cancer Res; 2009 Mar; 69(6):2167-70. PubMed ID: 19276354
[TBL] [Abstract][Full Text] [Related]
2. Control of senescence by CXCR2 and its ligands.
Acosta JC; O'Loghlen A; Banito A; Raguz S; Gil J
Cell Cycle; 2008 Oct; 7(19):2956-9. PubMed ID: 18838863
[TBL] [Abstract][Full Text] [Related]
3. Chemokine signaling via the CXCR2 receptor reinforces senescence.
Acosta JC; O'Loghlen A; Banito A; Guijarro MV; Augert A; Raguz S; Fumagalli M; Da Costa M; Brown C; Popov N; Takatsu Y; Melamed J; d'Adda di Fagagna F; Bernard D; Hernando E; Gil J
Cell; 2008 Jun; 133(6):1006-18. PubMed ID: 18555777
[TBL] [Abstract][Full Text] [Related]
4. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
5. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
6. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.
Lesina M; Wörmann SM; Morton J; Diakopoulos KN; Korneeva O; Wimmer M; Einwächter H; Sperveslage J; Demir IE; Kehl T; Saur D; Sipos B; Heikenwälder M; Steiner JM; Wang TC; Sansom OJ; Schmid RM; Algül H
J Clin Invest; 2016 Aug; 126(8):2919-32. PubMed ID: 27454298
[TBL] [Abstract][Full Text] [Related]
7. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
8. Senescence-Associated Secretory Phenotype Suppression Mediated by Small-Sized Mesenchymal Stem Cells Delays Cellular Senescence through TLR2 and TLR5 Signaling.
Kwon JH; Kim M; Um S; Lee HJ; Bae YK; Choi SJ; Hwang HH; Oh W; Jin HJ
Cells; 2021 Jan; 10(1):. PubMed ID: 33401590
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
[TBL] [Abstract][Full Text] [Related]
10. Discrete steps in binding and signaling of interleukin-8 with its receptor.
Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
[TBL] [Abstract][Full Text] [Related]
12. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
Wang B; Hendricks DT; Wamunyokoli F; Parker MI
Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.
Khurram SA; Bingle L; McCabe BM; Farthing PM; Whawell SA
J Oral Pathol Med; 2014 Oct; 43(9):667-74. PubMed ID: 24965032
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
Katancik JA; Sharma A; de Nardin E
Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
[TBL] [Abstract][Full Text] [Related]
15. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice.
Mizutani N; Nabe T; Yoshino S
J Immunol; 2014 Feb; 192(4):1372-84. PubMed ID: 24446518
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.
Lee CH; Syu SH; Liu KJ; Chu PY; Yang WC; Lin P; Shieh WY
Oncotarget; 2015 Nov; 6(36):38866-80. PubMed ID: 26462152
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage.
Guo H; Liu Z; Xu B; Hu H; Wei Z; Liu Q; Zhang X; Ding X; Wang Y; Zhao M; Gong Y; Shao C
Aging Cell; 2013 Dec; 12(6):1110-21. PubMed ID: 23869868
[TBL] [Abstract][Full Text] [Related]
18. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
19. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
20. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
